Europe Biopharmaceutical Contract Manufacturing Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Biopharmaceutical Contract Manufacturing Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Biopharmaceutical Contract Manufacturing Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Biopharmaceutical Contract Manufacturing Market Regional Analysis

6.2 Europe Biopharmaceutical Contract Manufacturing Market Revenue 2019-2028 (US$ Million)

6.3 Europe Biopharmaceutical Contract Manufacturing Market Forecast Analysis

7. Europe Biopharmaceutical Contract Manufacturing Market Analysis – by Product

7.1 Biologics

7.1.1 Overview
7.1.2 Biologics: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Biosimilar

7.2.1 Overview
7.2.2 Biosimilar: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Biopharmaceutical Contract Manufacturing Market Analysis – by Service

8.1 Process Development

8.1.1 Overview
8.1.2 Process Development: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Fill and Finish Operation

8.2.1 Overview
8.2.2 Fill and Finish Operation: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Analytical and QC Studies

8.3.1 Overview
8.3.2 Analytical and QC Studies: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Packaging

8.4.1 Overview
8.4.2 Packaging: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Biopharmaceutical Contract Manufacturing Market Analysis – by Source

9.1 Mammalian

9.1.1 Overview
9.1.2 Mammalian: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Microbial-Based Biologics/Non-Mammalian

9.2.1 Overview
9.2.2 Microbial-Based Biologics/Non-Mammalian : Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Europe Biopharmaceutical Contract Manufacturing Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 UK: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
10.2.1.1.2 UK: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
10.2.1.1.3 UK: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Source

10.2.1.2 Germany: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Germany: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
10.2.1.2.2 Germany: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
10.2.1.2.3 Germany: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Source

10.2.1.3 France: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 France: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
10.2.1.3.2 France: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
10.2.1.3.3 France: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Source

10.2.1.4 Russia: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Russia: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
10.2.1.4.2 Russia: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
10.2.1.4.3 Russia: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Source

10.2.1.5 Italy: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Italy: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
10.2.1.5.2 Italy: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
10.2.1.5.3 Italy: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Source

10.2.1.6 Rest of Europe: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
10.2.1.6.2 Rest of Europe: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
10.2.1.6.3 Rest of Europe: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Source

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 AbbVie Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Ajinomoto Co. Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Boehringer Ingelheim International GmbH

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 General Electric Company

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Lonza

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 MERCK KGAA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Samsung Biologics

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 THERMO FISHER SCIENTIFIC INC

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 WUXI BIOLOGICS

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Biopharmaceutical Contract Manufacturing Market

Analysis By Product (Biologics and Biosimilar), Service (Process Development, Fill and Finish Operation, Analytical and QC Studies, and Packaging), and Source (Mammalian and Microbial-Based Biologics/Non-Mammalian)